Europe blood culture tests market was valued at $1,284.3 million in 2021 and will grow by 8.4% annually over 2021-2031 owing to the rising prevalence of bloodstream infections, increasing number of sepsis cases and high cost of treatment, rising geriatric population, and the rising demand for rapid diagnostic techniques amid the COVID-19 pandemic.
Highlighted with 35 tables and 55 figures, this 110-page report Europe Blood Culture Tests Market 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe blood culture tests market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe blood culture tests market in every aspect of the classification from perspectives of Product, Method, Technology, Application, End User, and Country.
Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Consumables
o Blood Culture Media
o Assay Kits & Reagents
o Blood Culture Accessories
Instruments
o Automated Blood Culture Systems
o Supporting Laboratory Equipment
Software and Services
Based on Method, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Conventional/Manual Methods
Automated Methods
Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Culture-Based Technologies
Molecular Technologies
o Microarrays
o Polymerase Chain Reaction (PCR)
o PNA-FISH
Proteomics Technology
Other Technologies
Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Bacteremia
Fungemia
Mycobacterial Detection
Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other End Users
Geographically, the following national/local markets are fully investigated:
Germany
UK
France
Spain
Italy
Russia
Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioMrieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
